返回 Agenda
Session 4: Cutting Edge–Artificial Intelligence and 3D Printing Revolutionizing Materials, Design, and Manufacturing
Session Chair(s)
Ryan McGowan
Associate Director, Combination Products
AstraZeneca, United States
Emerging technologies hold great promise for the advancement of medical care and combination product development is no exception. Recent progress in the areas of material science and digital systems will hopefully result in more effective, customized, and efficient delivery of medicines and medical devices to the market. This session will provide an example of technologies that hold particular promise as well as the practical and regulatory implications of their use in combination products.
Learning Objective : At the conclusion of this session, the participant should be able to:- Describe relevant emerging technologies and their potential impact to combination product development and regulation
- Discuss recent regulatory guidance in the areas of emerging technologies and best practices for approaching regulators with novel product ideas
Speaker(s)
Artificial Intelligence and Machine Learning Technologies: Implications for Medical Products and Emerging FDA Policies
Bakul Patel, MBA, MS
Google Health, United States
Senior Director, Global Digital Health Strategy and Regulatory
Additive Printing Technologies: Applications in Combination Products and Beyond (Remote Presentation)
Michael Drues, PhD
Vascular Sciences, United States
Founder and President
Panel Discussion: Recommendations for Approaching the FDA with a Novel Technologies
Bakul Patel, MBA, MS
Google Health, United States
Senior Director, Global Digital Health Strategy and Regulatory
Michael Drues, PhD
Vascular Sciences, United States
Founder and President